When was Techcyte founded?

Techcyte was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Where is Techcyte located?

Techcyte is headquartered in Orem, United States. It is registered at 105 S. State Street #401, Orem, UT 84058, US.

How many employees does Techcyte have?

As of Sep 30, 2026, the latest employee count at Techcyte is 122.

Is Techcyte a funded company?

Techcyte is a funded company, having raised a total of $50.4M across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2016.

When was the latest funding round of Techcyte?

Techcyte's latest funding was a $***** Series B round on Apr 30, 2026, with participation from 2 investors.

Where does Techcyte rank among its competitors?

Techcyte ranks 6th amongst 259 active competitors, of which 78 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Techcyte, which secured $15M in Apr, 2026.

Who are the top competitors of Techcyte?

Techcyte's top competitors include PathAI, Deciphex and Aignostics. Among them, Techcyte secured the most recent funding round in April, 2026.

Techcyte - 2026 Company Profile, Team, Funding & Competitors

Company Details

Artificial intelligence (AI) based image analysis platform for pathologists. The tool called Techcyte uses several Artificial intelligence (AI) platforms to perform image analysis on digital microscopy images. Also developing AI-based digital analysis tools for hematology tests, cervical cytology tests, ova and parasites (O&P) fecal tests for humans as well as animal samples. The company has collaborated with Motic, a leading provider of whole slide scanners to provide advanced solutions for scanning, image analysis, workflow, and reporting recently.

Website: techcyte.com
Social
Email ID: *****@techcyte.com
Phone Number: +1 **********
Registered Address: 105 S. State Street #401, Orem, UT 84058, US

Key Metrics

Founded Year

2014

Location

Orem, United States

Stage

Series B

Total Funding

$50.4M in 5 rounds

Latest Funding Round

Series B, Apr 30, 2026, $*****

Investors

Zoetis & 3 more

Ranked

6^th among 259 active competitors

Employee Count

122 as on Sep 30, 2026

Similar Companies

OpenEvidence & 3086 more

View Techcyte's full profile

Techcyte is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Techcyte, Inc. CIN: 20241608097 , United States, Active	Jun 03, 2024	-	-	-

Techcyte has raised a total funding of $50.4M over 5 rounds. Its first funding round was on 2016. Its latest funding round was a Series B round on Apr 30, 2026 for $*****. 2 investors participated in its latest round. Techcyte has 4 institutional investors.

Here is the list of recent funding rounds of Techcyte:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 30, 2026	4115816	Series B	1485587	6743955	1754021	8992764
Dec 22, 2023	1536591	Series B	9997367	8417355	2436497	3134070
Aug 19, 2021	3195772	Series B	5307313	7794480	Zoetis & 1 more	1944273

Access funding benchmarks and valuations. Sign up today!

View details of Techcyte's funding rounds and investors

The founders of Techcyte is Ralph Yarro.

Here are the details of Techcyte's key team members:

Ralph Yarro: Founder & CEO of Techcyte and founder of 1 other company. They serve on the board of 1 company.
Contact Info: 2 email addresses

Techcyte's Board of Directors

Techcyte's board has 10 active members. Richard Smith, Ralph Yarro, Kyle Wilson, Michael Aicher, Kent Gordon, Mohammed Salama, Ben Cahoon, Michael Wolfgramm, William Dorsey and Jay Tolley are independent board members.

Here is the list of Techcyte's board of directors:

Name	Type	Representing	Status	Duration
Richard Smith	Independent board member	-	Current	5y 0m
ywmbntc	Independent board member	-	Current	3y 1m
edykymf	Independent board member	-	Current	1y 3m
grvmhaa	Independent board member	-	Current	9y 7m
fvbeaow	Independent board member	-	Current	5y 3m
knynhsl	Independent board member	-	Current	7y 9m
rytcxqv	Independent board member	-	Current	1y 6m
lkls{km	Independent board member	-	Current	4y 4m
ihzskry	Independent board member	-	Current	2y 2m
knxoqiy	Independent board member	-	Current	9y 1m

View details of Techcyte's Founder profiles and Board Members

Techcyte's employee count trend

Techcyte has 122 employees as of Sep 26. Here is Techcyte's employee count trend over the years:

Uncover Techcyte's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Techcyte include PathAI, Deciphex and Aignostics. Here is the list of Top 10 competitors of Techcyte, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PathAI 2016, Boston (United States), Series C	Provider of digital pathology image management system for clinical labs	$255M	General Catalyst, General Atlantic & 22 others	70/100
2nd	Deciphex 2017, Dublin (Ireland), Series C	Network of pathologists providing digital diagnostic services for medical testing	$56.6M	Seroba Life Sciences, Molten Ventures & 13 others	65/100
3rd	Aignostics 2018, Berlin (Germany), Series B	Developer of artificial intelligence software for biomedical image analysis applications	$53.9M	Wellington Partners Venture Capital, Boehringer Ingelheim Venture Fund ... & 9 others	64/100
4th	Aiforia 2014, Helsinki (Finland), Public	Provider of an AI and cloud-based, deep learning image analysis platform in all therapy areas	$23M	Ascend Capital Partners, Businessfinland & 8 others	64/100
5th	Nucle AI 2017, Chicago (United States), Series B	AI-assisted platform for image analysis	$60M	Vertex Ventures Israel, Sanofi Ventures & 9 others	62/100
6th	Techcyte 2014, Orem (United States), Series B	Artificial intelligence (AI) based image analysis platform for pathologists	$50.4M	Atua Ventures, ARUP Laboratories & 2 others	62/100
7th	Onc.ai 2020, San Carlos (United States), Series A	AI-based cancer treatment and diagnosis platform for healthcare providers	$31M	Accomplice, MassMutual & 12 others	61/100
8th	Visiopharm 2001, Horsholm (Denmark), Acquired	Developer of a SaaS and AI-based digital pathology solutions for image analysis and workflow standardization	$26.3M	BankInvest, Vaekstfonden & 4 others	60/100
9th	PAIGE 2018, New York City (United States), Acquired	Developer of AI applications and foundation models for cancer diagnostics	$241M	Goldman Sachs, Casdin Capital & 9 others	59/100
10th	Proscia 2014, Philadelphia (United States), Series C	Provider of an AI and cloud-based digital pathology solution for cancer diagnosis	$129M	Triangle Peak Partners, TEDCO & 22 others	59/100